Margaret Mordin
RTI Health Solutions(US)
Publications by Year
Research Areas
Health Systems, Economic Evaluations, Quality of Life, Pharmaceutical Economics and Policy, Psoriasis: Treatment and Pathogenesis, Statistical Methods in Clinical Trials, Dermatology and Skin Diseases
Most-Cited Works
- → A Review of Patient-Reported Outcome Labels in the United States: 2006 to 2010(2012)127 cited
- → Validation of the Knee Injury and Osteoarthritis Outcome Score Subscales for Patients With Articular Cartilage Lesions of the Knee(2012)82 cited
- → Assessment of PRO Label Claims Granted by the FDA as Compared to the EMA (2006–2010)(2013)78 cited
- → Effects of Alefacept on Health-Related Quality of Life in Patients with Psoriasis(2003)75 cited
- → A Review of Patient-Reported Outcome Labeling in the United States (2011–2015)(2016)58 cited
- → Psoriasis patients with psoriasis Area and Severity Index (PASI) 90 response achieve greater health-related quality-of-life improvements than those with PASI 75–89 response: results from two phase 3 studies of secukinumab(2017)56 cited
- → Reasons for Rejection of Patient-Reported Outcome Label Claims: A Compilation Based on a Review of Patient-Reported Outcome Use among New Molecular Entities and Biologic License Applications, 2006–2010(2012)50 cited
- → Factors affecting the health-related quality of life of patients with cervical dystonia and impact of treatment with abobotulinumtoxinA (Dysport): results from a randomised, double-blind, placebo-controlled study(2014)45 cited
- → Development of a Conceptual Model of Adherence to Oral Anticoagulants to Reduce Risk of Stroke in Patients with Atrial Fibrillation(2012)44 cited
- → Secukinumab improves patient‐reported psoriasis symptoms of itching, pain, and scaling: results of two phase 3, randomized, placebo‐controlled clinical trials(2016)42 cited